127 research outputs found
Influence of XRCC1 Genetic Polymorphisms on Ionizing Radiation-Induced DNA Damage and Repair
It is well known that ionizing radiation (IR) can damage DNA through a direct action, producing single- and double-strand breaks on DNA double helix, as well as an indirect effect by generating oxygen reactive species in the cells. Mammals have evolved several and distinct DNA repair pathways in order to maintain genomic stability and avoid tumour cell transformation. This review reports important data showing a huge interindividual variability on sensitivity to IR and in susceptibility to developing cancer; this variability is principally represented by genetic polymorphisms, that is, DNA repair gene polymorphisms. In particular we have focussed on single nucleotide polymorphisms (SNPs) of XRCC1, a gene that encodes for a scaffold protein involved basically in Base Excision Repair (BER). In this paper we have reported and presented recent studies that show an influence of XRCC1 variants on DNA repair capacity and susceptibility to breast cancer
DNA damage repair and genetic polymorphisms: Assessment of individual sensitivity and repair capacity
n/
Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis
Increased oxidative stress is known to play a role in the pathogenesis of atherosclerosis, and polymorphisms in genes encoding for enzymes involved in modulation of oxidant stress, such as paraoxonases (PONs), provide a potentially powerful approach to study the risk of disease susceptibility. Aim of our study is to investigate the possible association among PONs polymorphisms, clinical and metabolic factors, and atherothrombotic events in an Italian population. We evaluated in 105 subjects, with or without atherosclerotic risk factors, the presence of PON1 L55M, PON1 Q192R, and PON2 S311C genetic variants, as well as lipid profile, the concentration of aminothiols (blood reduced glutathione, plasma total glutathione, homocysteine, cysteine, cysteinyl glycine), and malondialdehyde as markers of lipid peroxidation
Morphology of the Stomach of Tayra (Eira barbara)
Background: The Tayra (Eira barbara) is a mammal of the family Mustelidae with a significant presence in Latin America, it is considered an opportunist and extremely agile omnivorous. Some organs compose the digestive system and the stomach is a substantial organ for this system. The stomach have a small and a large curvature and the regions of the cardia, fundus, body and pylorus. Histologically, the stomach is made up of four layers or tunics that contributes in digestive functions. However, due the limited information available in the literature about morphophysiology of wildlife, this study aimed to clarify the morphology of Eira barbara stomach to understand your digestive system.Materials, Methods & Results: Three males and three females of Eira barbara species were studied (all young adults), all samples were originated of the Bauxite Mine area, in Paragominas, Pará state, Brazil provided of donation to Morphological Animal Research Laboratory (LaPMa) of the Universidade Federal Rural da Amazonia (UFRA), after death by trampling. The corpses were treated with aqueous 10% formaldehyde solution intramuscular injections, subcutaneous and intracavitary. After dissection, the collected material was processed following histologic standard protocols for the subsequent preparation of slides. The studied animals showed the stomach on the left antimere the abdominal cavity, with saccular format with the presence of large and small curvatures. The organ showed composite mucosa made with various gastric folds distributed in regions of the cardia, fundus and pylorus. A microscopic analysis of Eira barbara stomach revealed the presence of tunics or layers which gradually invaginate the lumen of the organ and underlying lamina propria was located to the prismatic epithelium and muscular mucosae and mucosa itself. In the region of the cardia, the muscle layer was deeply situated on the lamina propria, consisting of smooth muscle tissue with circular and longitudinal fibers. The submucosa consists of loose connective tissue; it is much thicker than the lamina propria and has many vessels. The first portion of the stomach showed long glands, while with short pits. In light microscopy, the fundic region revealed the presence of a highly pleated epithelium with elongated glands composed of clear and basally placed cells, with flattened nuclei. These cells are named mucous. Along the short region of the gastric pits, the presence of large cells was reported, pyramidal or rounded, central nucleus, called parietal. The pyloric region microscopy revealed the presence of short glands, similar to those previously described in the cardia region. The wide presence of goblet cells in the final portion of the pylorus indicated gradual transition between the regions of the stomach to the intestine, called duodenum-pylorus transition. The muscular layer showed thick muscle bundles just in circular direction, being responsible for the formation of the pyloric sphincter.Discussion: The morphological analysis of the stomachs showed morphological and topographical similarities to the literature description for pets and wild mammals, however, were found in abundant quantities goblet cells in the transition duodenal pylorus. The goblet cells are located throughout the length of the small and large intestine and are responsible for the production and maintenance of the protective mucus synthesizing as glycoproteins known as mucins
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas
Background: Prolactinoma, the most common pituitary adenoma, is usually treated with dopamine agonist (DA) therapy like cabergoline. Surgery is second-line therapy, and radiotherapy is used if surgical treatment fails or in relapsing macroprolactinoma. Objective: This study aimed to provide economic evidence for the management of prolactinoma in Italy, using a cost-of-illness and cost-utility analysis that considered various treatment options, including cabergoline, bromocriptine, temozolomide, radiation therapy, and surgical strategies. Methods: The researchers conducted a systematic literature review for each research question on scientific data- bases and surveyed a panel of experts for each therapeutic procedure's specific drivers that contributed to its total cost. Results: The average cost of the first year of treatment was euro2,558.91 and euro3,287.40 for subjects with micro- prolactinoma and macroprolactinoma, respectively. Follow-up costs from the second to the fifth year after ini- tial treatment were euro798.13 and euro1,084.59 per year in both groups. Cabergoline had an adequate cost-utility profile, with an incremental cost-effectiveness ratio (ICER) of euro3,201.15 compared to bromocriptine, based on a willingness-to-pay of euro40,000 per quality-adjusted life year (QALY) in the reference economy. Endoscopic sur- gery was more cost-effective than cabergoline, with an ICER of euro44,846.64. Considering a willingness-to-pay of euro40,000/QALY, the baseline findings show cabergoline to have high cost utility and endoscopic surgery just a tad above that. Conclusions: Due to the favorable cost-utility profile and safety of surgical treatment, pituitary surgery should be considered more frequently as the initial therapeutic approach. This management choice could lead to better outcomes and an appropriate allocation of healthcare resources
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.
Objectives To determine whether progressive skin fibrosis is associated with visceral organ progression and mortality during follow-up in patients with diffuse cutaneous systemic sclerosis (dcSSc). Methods We evaluated patients from the European Scleroderma Trials and Research database with dcSSc, baseline modified Rodnan skin score (mRSS) ≥7, valid mRSS at 12±3 months after baseline and ≥1 annual follow-up visit. Progressive skin fibrosis was defined as an increase in mRSS >5 and ≥25% from baseline to 12±3 months. Outcomes were pulmonary, cardiovascular and renal progression, and all-cause death. Associations between skin progression and outcomes were evaluated by Kaplan-Meier survival analysis and multivariable Cox regression. Results Of 1021 included patients, 78 (7.6%) had progressive skin fibrosis (skin progressors). Median follow-up was 3.4 years. Survival analyses indicated that skin progressors had a significantly higher probability of FVC decline ≥10% (53.6% vs 34.4%; p<0.001) and all-cause death (15.4% vs 7.3%; p=0.003) than non-progressors. These significant associations were also found in subgroup analyses of patients with either low baseline mRSS (≤22/51) or short disease duration (≤15 months). In multivariable analyses, skin progression within 1 year was independently associated with FVC decline ≥10% (HR 1.79, 95% CI 1.20 to 2.65) and all-cause death (HR 2.58, 95% CI 1.31 to 5.09). Conclusions Progressive skin fibrosis within 1 year is associated with decline in lung function and worse survival in dcSSc during follow-up. These results confirm mRSS as a surrogate marker in dcSSc, which will be helpful for cohort enrichment in future trials and risk stratification in clinical practice
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study
Objectives. Racial factors play a significant role in SSc. We evaluated differences in SSc presentations between white patients (WP), Asian patients (AP) and black patients (BP) and analysed the effects of geographical locations.Methods. SSc characteristics of patients from the EUSTAR cohort were cross-sectionally compared across racial groups using survival and multiple logistic regression analyses.Results. The study included 9162 WP, 341 AP and 181 BP. AP developed the first non-RP feature faster than WP but slower than BP. AP were less frequently anti-centromere (ACA; odds ratio (OR) = 0.4, P < 0.001) and more frequently anti-topoisomerase-I autoantibodies (ATA) positive (OR = 1.2, P = 0.068), while BP were less likely to be ACA and ATA positive than were WP [OR(ACA) = 0.3, P < 0.001; OR(ATA) = 0.5, P = 0.020]. AP had less often (OR = 0.7, P = 0.06) and BP more often (OR = 2.7, P < 0.001) diffuse skin involvement than had WP.AP and BP were more likely to have pulmonary hypertension [OR(AP) = 2.6, P < 0.001; OR(BP) = 2.7, P = 0.03 vs WP] and a reduced forced vital capacity [OR(AP) = 2.5, P < 0.001; OR(BP) = 2.4, P < 0.004] than were WP. AP more often had an impaired diffusing capacity of the lung than had BP and WP [OR(AP vs BP) = 1.9, P = 0.038; OR(AP vs WP) = 2.4, P < 0.001]. After RP onset, AP and BP had a higher hazard to die than had WP [hazard ratio (HR) (AP) = 1.6, P = 0.011; HR(BP) = 2.1, P < 0.001].Conclusion. Compared with WP, and mostly independent of geographical location, AP have a faster and earlier disease onset with high prevalences of ATA, pulmonary hypertension and forced vital capacity impairment and higher mortality. BP had the fastest disease onset, a high prevalence of diffuse skin involvement and nominally the highest mortality
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Chemical composition of flours made of residues from the king palm (Archontophoenix alexandrae) industry
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
- …